Hesp prevents malignant transformation and cancer progression by targeting molecular mechanisms involved in tumor cell survival, proliferation, and apoptosis through upregulation of Bax and caspase-3, downregulation of Bcl-2, and stimulation of NF-κB and AKT/mTOR signaling pathways [12,13]. The gene discussed is BAX; the disease is cancer.